欢迎光临~北京凯森莱科技有限公司
语言选择: 中文版 ∷  英文版

70753-61-6,L-苏糖酸钙, Calcium L-Threonate ,CaLT, Cas:70753-61-6

70753-61-6,L-苏糖酸钙,
Calcium L-Threonate ,CaLT,
Cas:70753-61-6
MFCD00077882
C8H14CaO10 / 310.27

L-苏糖酸钙,Calcium L-Threonate ,CaLT,

Calcium L-Threonate (CaLT) is a calcium salt of L-threonate, a natural metabolite of vitamin C in mammals. CaLT has gained attention as a promising chemical compound for its potential applications in various fields of research and industry. In this paper, we will provide an overview of CaLT, including its definition and background, physical and chemical properties, synthesis and characterization, analytical methods, biological properties, toxicity and safety in scientific experiments, applications in scientific experiments, current state of research, potential implications in various fields of research and industry, limitations and future directions.

Definition and Background:

CaLT was first synthesized in 1998 by scientists at the Scripps Research Institute in Florida. The compound’s potential use in treating Alzheimer’s disease (AD) was discovered by scientists at Massachusetts Institute of Technology, who showed that CaLT was able to restore cognitive function in aging rats. Since then, research on the compound has grown, focusing on its potential use in treating a variety of neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.

Physical and Chemical Properties:

CaLT is a white crystalline powder that is insoluble in water and organic solvents. It has a molecular weight of 310.27 g/mol and is highly hygroscopic (meaning it absorbs moisture from the air). CaLT has a melting point of 265-270°C and a boiling point of 640°C.

Synthesis and Characterization:

CaLT is synthesized by reacting calcium oxide or calcium hydroxide with L-threonic acid in water. The resulting compound is then purified through filtration and recrystallization. CaLT can be characterized through a variety of analytical techniques, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and infrared (IR) spectroscopy.

Analytical Methods:

Several analytical methods can be used to measure the concentration and purity of CaLT. These include high-performance liquid chromatography (HPLC), mass spectrometry (MS), and spectrophotometry.

Biological Properties:

Studies have shown that CaLT has several biological properties that make it promising for the treatment of neurodegenerative disorders. It has been shown to increase the activity of astrocytes (cells that provide support to neurons), which in turn can improve cognitive function. CaLT has also been shown to increase the synthesis and release of acetylcholine, a neurotransmitter that is important for memory and learning. In addition, CaLT has been shown to have antioxidant properties and to protect neurons from damage caused by oxidative stress.

Toxicity and Safety in Scientific Experiments:

Studies have shown that CaLT is generally well-tolerated and has low toxicity in animals. However, further safety studies are needed to determine the toxicity and safety in clinical trials.

Applications in Scientific Experiments:

CaLT has various applications in scientific experiments. In preclinical studies, CaLT has been shown to improve cognitive function in animal models of AD, Parkinson’s disease, and Huntington’s disease. In addition, CaLT has been shown to have potential therapeutic effects on other neurological conditions, such as depression and anxiety.

Current State of Research:

Currently, there are several ongoing studies investigating the potential applications of CaLT in the treatment of neurodegenerative disorders. One of the few available human studies observed a placebo-controlled clinical trial of CaLT in elderly subjects with cognitive decline. Results showed a significant improvement in both subjective and objective cognitive function in the CaLT-treated group compared to the placebo group. However, further large-scaled studies will be required to confirm the clinical efficiency of CaLT.

Potential Implications in Various Fields of Research and Industry:

Given the promising therapeutic potential of CaLT described in research studies, there are a wide range of potential implications in various fields of research and industry. CaLT could serve as a treatment for AD and other neurodegenerative disorders, but it could also have broader applications in the field of mental health.

Limitations and Future Directions:

Although CaLT has been shown to have potential therapeutic effects in preclinical and early-phase clinical trials, there are still several limitations to the use of CaLT in humans. First, the safety of long-term CaLT intake requires further study. Additionally, the most effective oral/parenteral administration route, dosage, and duration of treatment still need to be determined through additional studies.

Future Directions:

Due to the high prospects of CaLT's therapeutic potential, researchers have suggested several potential future directions for CaLT's applications:

1. Combination Therapy: There is potential to use CaLT in combination with existing therapies for the treatment of neurodegenerative disorders to enhance the therapeutic efficacy of current treatments.

2. Exploration in Other Diseases: Comprehensive research needs to investigate the therapeutic potential of CaLT in other diseases such as muscular dystrophy, neuropathic pain, and Traumatic Brain Injury (TBI).

3. Identification of Co-Administration Drugs: CaLT could be co-administered with certain drugs to evocate its potentials in transforming the health of certain diseased people based on various research studies.

4. Novel Delivery System: It is essential to develop a more efficient CaLT delivery system to increase absorption and bioavailability of CaLT within the body.

In conclusion, CaLT is a promising compound for the future with potential applications in various fields of scientific research and industry, especially in the treatment of neurodegenerative disorders. While the effects of CaLT are yet to be proven in clinical trials, research has shown its potential to improve cognitive function and bring relief to neurological conditions that are currently untreatable. With the support of continuing research and funding and broad utilization of knowledge from research studies, CaLT can transform the healthcare industry.

CAS Number70753-61-6
Product NameCalcium L-Threonate
IUPAC Namecalcium;(2R,3S)-2,3,4-trihydroxybutanoate
Molecular FormulaC8H14CaO10
Molecular Weight310.27 g/mol
InChIInChI=1S/2C4H8O5.Ca/c2*5-1-2(6)3(7)4(8)9;/h2*2-3,5-7H,1H2,(H,8,9);/q;;+2/p-2/t2*2-,3+;/m00./s1
InChI KeyZJXGOFZGZFVRHK-BALCVSAKSA-L
SMILESC(C(C(C(=O)[O-])O)O)O.C(C(C(C(=O)[O-])O)O)O.[Ca+2]
SolubilitySoluble
Synonyms2,3,4-trihydroxy-(threo)-butanoic acid, calcium l-threonate, calcium threonate, ClariMem, L-TAMS compound, L-threonic acid magnesium salt, magnesium threonate, MMFS-01, threonate, threonic acid, threonic acid, (R*,R*)-isomer, threonic acid, (R-(R*,S*))-isomer, threonic acid, dl-, threonic acid, l-
Canonical SMILESC(C(C(C(=O)[O-])O)O)O.C(C(C(C(=O)[O-])O)O)O.[Ca+2]
Isomeric SMILESC([C@@H]([C@H](C(=O)[O-])O)O)O.C([C@@H]([C@H](C(=O)[O-])O)O)O.[Ca+2]


在线询价

用手机扫描二维码关闭
二维码